Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

137 Results

Toronto Central Regional Cancer Program

Thyroid Cancer Pathway Map

Guidelines and Advice

Thalidomide in Multiple Myeloma

Status: Archived
ID: 6-21

Jan 2010

Thymic Cancer Pathway Map

Guidelines and Advice

The Use of Cabazitaxel in Men with Castrate Resistant Metastatic Prostate Cancer Previously Treated with Docetaxel

Status: Archived
ID: CED 23

Oct 2011

Guidelines and Advice

The Use of Leucovorin in Colorectal Cancer

Status: Archived
ID: 12-17

Feb 2016

Guidelines and Advice

The Role of Porfimer Sodium (PhotofrinTM) in the Ablation of High-Grade Dysplasia in Barrett's Esophagus

Status: Archived
ID: CED 2
Version: 2

Jan 2006

Guidelines and Advice

The Use of Chemotherapy and Growth Factors in Older Patients with Newly Diagnosed, Advanced Stage, Aggressive Histology Non-Hodgkin's Lymphoma

Status: Education and Information
ID: 6-7 Version 2
Version: 2

Jun 2013

Guidelines and Advice

T-Cell Engaging Antibodies: Management of Cytokine Release Syndrome (CRS) and Immune Effector-Associated Neurotoxicity Syndrome (ICANS)

Status: Current

Updated

Mar 2025

Guidelines and Advice

The Use of Epidermal Growth Factor Receptor Inhibitors in Advanced Colorectal Cancer

Status: Archived
ID: CED 8

Jul 2008

Guidelines and Advice

The Use of Imatinib Mesylate (GleevecTM) in Patients with Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Status: Archived
ID: CED 10

Sep 2008

Guidelines and Advice

The Prognostic Value of the DNMT3A Biomarker in Cytogenetically Normal Patients with Acute Myeloid Leukemia

Status: Archived
ID: MOAC 1

Nov 2013

Pages